214 results on '"El-Chami, Mikhael F."'
Search Results
2. Predictive value of the PRAETORIAN score for defibrillation test success in patients with subcutaneous ICD: A subanalysis of the PRAETORIAN-DFT trial
3. Managing superior vena cava syndrome in patients with cardiac implantable electronic device leads: Strategies and considerations
4. A leadless ventricular pacemaker providing atrioventricular synchronous pacing in the real-world setting: 12-Month results from the Micra AV post-approval registry
5. Accurate detection of lead malfunction from ECG-derived bipolar pacing stimulus amplitude
6. Outcomes of patients implanted with an atrioventricular synchronous leadless ventricular pacemaker in the Medicare population
7. Safety of same-day discharge after lead extraction procedures
8. Ambulatory atrioventricular synchronous pacing over time using a leadless ventricular pacemaker: Primary results from the AccelAV study
9. Infection in patients with subcutaneous implantable cardioverter-defibrillator: Results of the S-ICD Post Approval Study
10. Temporal trends of device-related infection in de novo transvenous implantable cardioverter-defibrillator Medicare patients with underlying kidney disease
11. Leadless pacemaker implant, anticoagulation status, and outcomes: Results from the Micra Transcatheter Pacing System Post-Approval Registry
12. Device-related infection in de novo transvenous implantable cardioverter-defibrillator Medicare patients
13. Relationship between device-detected burden and duration of atrial fibrillation and risk of ischemic stroke
14. Morbidity and mortality in patients precluded for transvenous pacemaker implantation: Experience with a leadless pacemaker
15. Outcomes of subcutaneous implantable cardioverter-defibrillator in dialysis patients: Results from the S-ICD post-approval study
16. Leadless pacemakers reduce risk of device-related infection: Review of the potential mechanisms
17. Understanding Outcomes with the EMBLEM S-ICD in Primary Prevention Patients with Low EF Study (UNTOUCHED): Clinical characteristics and perioperative results
18. Long-term performance of a pacing lead family: A single-center experience
19. PO-03-058 S-ICD GENERATOR EXCHANGE AND PERFORMANCE: A SINGLE TERTIARY CARE EXPERIENCE
20. CI-452768-4 THE MICRA AV LEADLESS PACEMAKER IN THE REAL-WORLD MEDICARE POPULATION: EARLY RESULTS FROM THE MICRA AV COVERAGE WITH EVIDENCE DEVELOPMENT (CED) STUDY
21. PO-03-135 LEFT ATRIAL APPENDAGE OCCLUSION VERSUS STANDARD OF CARE IN PATIENTS WITH ATRIAL FIBRILLATION AND A PRIOR THROMBO-EMBOLIC EVENT DESPITE ORAL ANTICOAGULANT THERAPY: A PROPENSITY SCORE MATCHED COMPARISON
22. MP-453086-5 QUALITY OF LIFE AFTER SHOCKS OR COMPLICATIONS IS SIMILAR BETWEEN SUBCUTANEOUS AND TRANSVENOUS DEFIBRILLATOR THERAPY
23. LB-456087-1 FIRST RESULTS OF THE RANDOMIZED PRAETORIAN-DFT TRIAL: PROSPECTIVE VALIDATION OF THE PRAETORIAN SCORE FOR PREDICTION OF DEFIBRILLATION TEST SUCCESS AFTER SUBCUTANEOUS ICD IMPLANT
24. MP-453091-11 INCIDENCE, REASONS FOR, AND PREDICTORS OF DISCONTINUATION OF DOFETILIDE THERAPY
25. PO-05-025 LONGER TERM OUTCOMES IN PATIENTS PRECLUDED FOR TRANSVENOUS PACEMAKER IMPLANTATION: EXPERIENCE WITH THE MICRA VR TRANSCATHETER PACEMAKER
26. CI-452769-2 PERFORMANCE OF LEADLESS PACEMAKERS IN EXTENDED FOLLOW-UP: 5 YEAR RESULTS FROM THE MICRA VR TRANSCATHETER PACING SYSTEM POST-APPROVAL REGISTRY
27. How to Implant Leadless Pacemakers and Mitigate Major Complications
28. PO-707-02 SAFETY OF SAME DAY DISCHARGE AFTER LEAD EXTRACTION PROCEDURES
29. PO-647-02 MECHANISM, PREDICTORS AND SAFETY OF INAPPROPRIATE THERAPY IN THE PRAETORIAN TRIAL
30. CI-525-01 EARLY EXPERIENCE WITH A LEADLESS VENTRICULAR PACEMAKER PROVIDING ATRIOVENTRICULAR SYNCHRONOUS PACING IN THE REAL-WORLD SETTING: RESULTS FROM THE MICRA AV POST-APPROVAL REGISTRY
31. PO-619-01 SAFETY AND FEASIBILITY OF LEADLESS PACEMAKER IMPLANTATION VIA A LEFT FEMORAL VEIN APPROACH: EXPERIENCE WITH THE MICRA TRANSCATHETER PACEMAKER
32. PO-616-06 THE SPATIOTEMPORAL ORGANIZATION OF VENTRICULAR FIBRILLATION (VF) IN EXPLANTED HUMAN HEARTS
33. PO-632-05 LONG-TERM FOLLOW-UP ON PERFORMANCE OF SINGLE-CONNECTOR (DF4) IMPLANTABLE DEFIBRILLATOR LEADS: EXPERIENCE FROM A SINGLE TERTIARY CARE/REFERRAL CENTER
34. PO-633-02 THE IMPACT OF INCISION TECHNIQUE ON INAPPROPRIATE SHOCK RATES IN THE UNTOUCHED STUDY
35. PO-632-04 PATTERNS OF DEVICE-RELATED INFECTION IN DE NOVO TRANSVENOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR MEDICARE PATIENTS WITH UNDERLYING RENAL DISEASE
36. CI-524-01 THE IMPACT OF SMART PASS ALGORITHM STATUS ON INAPPROPRIATE SHOCK RATES IN THE UNTOUCHED STUDY
37. PO-620-06 VALIDATION OF RISK SCORE PREDICTING NEED FOR PACEMAKER IMPLANT AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT
38. PO-677-02 NEED FOR CARDIAC RESYNCHRONIZATION THERAPY UPGRADE WITH LEADLESS PACEMAKERS: EXPERIENCE WITH THE MICRA TRANSCATHETER PACEMAKER
39. PO-705-01 ACTION POTENTIAL RESTITUTION CURVES OBTAINED FROM FULL EXPLANTED HUMAN HEARTS
40. PO-621-02 EXTRACTION OF LEADS ACROSS THE TRICUSPID VALVE DOES NOT SIGNIFICANTLY ALTER TRICUSPID VALVE REGURGITATION
41. PO-05-143 SHORTER DIAGNOSIS-TO-ABLATION TIME IS ASSOCIATED WITH IMPROVED CLINICAL OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION
42. PO-04-176 THE IMPACT OF CHRONIC KIDNEY DISEASE ON HEALTHCARE UTILIZATION AND COSTS ASSOCIATED WITH CARDIAC IMPLANTABLE ELECTRONIC DEVICE INFECTION
43. PO-04-161 PATIENTS WITH NORMAL BMI ARE LESS PRONE TO COMPLICATIONS WHEN IMPLANTED WITH A SUBCUTANEOUS ICD COMPARED TO TRANSVENOUS ICD
44. PO-03-037 TWO-YEAR OUTCOMES OF MICRA AV LEADLESS PACEMAKERS IN THE MICRA AV CED STUDY
45. PO-02-172 OUTCOMES OF PRIMARY AND SECONDARY PREVENTION SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR: A SINGLE-CENTER EXPERIENCE
46. MP-470553-008 RISING BURDEN OF STROKE AND ATRIAL FIBRILLATION RELATED MORTALITY IN THE UNITED STATES FROM 1999-2020
47. MP-470545-009 TRENDS AND PREDICTORS OF INAPPROPRIATE SHOCKS IN PATIENTS WITH SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
48. MP-470545-007 GENDER BASED OUTCOMES OF SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
49. MP-470545-005 PREDICTORS OF MONOMORPHIC VENTRICULAR TACHYCARDIA IN PATIENTS WITH SUBCUTANEOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS
50. CE-482889-005 THE IMPACT OF SEX ON OUTCOMES ASSOCIATED WITH THE SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.